Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII

Pathophysiology of Haemostasis and Thrombosis

Volumn 35, Issue 5, 2007, Pages 405-407

  Koyama, Takatoshi ^a   Nagao, Toshikage ^a   Tsunozaki, Hidefumi ^a   Arai, Morio ^b   Miura, Osamu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 10A; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT BLOOD CLOTTING FACTOR 8; RICONATE; TRANEXAMIC ACID; UNCLASSIFIED DRUG;

ABDOMINAL DRAINAGE; ADULT; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DEBRIDEMENT; DRUG EFFECT; DRUG MEGADOSE; ERYTHROCYTE CONCENTRATE; HEMATOMA; HEMOPERITONEUM; HEMOPHILIA A; HEMOSTASIS; HEPATITIS C VIRUS; HERNIORRHAPHY; HUMAN; HYPOVOLEMIC SHOCK; INGUINAL HERNIA; LOADING DRUG DOSE; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; REOPERATION; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

AUTOANTIBODIES; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; FACTOR VII; FACTOR VIII; HEMATOMA; HEMOPHILIA A; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PERITONEUM; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 33846422736     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097697     Document Type: Article

References (7)

1. Quintana-Molina M, Martinez-Bahamonde F, Gonzalez-Garcia E, Romero-Garrido J, Villar-Camacho A, Jimenez-Yuste V, Fernandez-Bello I, Hernandez-Navarro F: Surgery in haemophilic patients with inhibitor: 20 years of experience. Haemophilia 2004;10(suppl 2):30-40.
2. Kasper CK: Treatment of factor VIII inhibitors. Prog Hemost Thromb 1989;9:57-86.
3. Lisman T, Mosnier LO, Lambert T, Mauser-Bunschoten EP, Meijers JC, Nieuwenhuis HK, de Groot PG: Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A. Blood 2002;99:175-179.
4. Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN: The defective down-regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration. Thromb Haemost 2001;86:1035-1039.
5. Roberts HR, Monroe DM, White GC: The use of recombinant factor VIIa in the treatment of bleeding disorders. Blood 2004;104:3858-3864.
6. Monroe DM, Hoffman M, Oliver JA, Roberts HR: Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997;99:542-547.
7. Monahan PE, Gold SH: Resistant recurrent hemarthrosis halted by sequential therapy with activated prothrombin complex concentrates (aPCCs) and recombinant factor VIIa (abstract). J Thromb Haemost 2005;3(suppl 1):P0836.